Point-of-care tests in behavioral health

Behavioral Healthcare

Volumn 26, Issue 4, 2006, Pages 37-39

  Glazer, William M ^a  

^a ReliaLab ^*

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM;

ARTICLE; ECONOMICS; HOSPITAL INFORMATION SYSTEM; HUMAN; MENTAL HEALTH SERVICE; METHODOLOGY; MONITORING; UNITED STATES;

HUMANS; LITHIUM; MENTAL HEALTH SERVICES; MONITORING, PHYSIOLOGIC; POINT-OF-CARE SYSTEMS; UNITED STATES;

EID: 33745122207     PISSN: 19317093     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Braceland FJ, Meduna LJ, Vaichulis JA. Delayed action of insulin in schizophrenia. Am J Psychiatry 1945; 102 = 108-110.
2. Cassidy F, Ahearn E, Carroll BJ. Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am J Psychiatry 1999;156:1417-20.
3. Rettenbacher MA. Disturbances of glucose and lipid metabolism during treatment with new generation antipsychotics. Curr Opin Psychiatry 2005:18:175-9.
4. Straker D, Correll CU, Kramer-Ginsberg E, et al. Cost-effective screening for the metabolic syndrome in patients treated with second-generation antipsychotic medications. Am J Psychiatry 2005;162:1217-21.
5. Goodwin FK. Rationale for long-term treatment of bipolar disorder and evidence for long-term lithium treatment. J Clin Psychiatry 2002;63(suppl 10):5-12.
6. Jefferson JW. Rediscovering the art of lithium therapy. Current Psychiatry 2002;1(12):19-24.
7. Tondo L, Jamison KR, Baidessarini RJ. Effect of lithium maintenance on suicidal behavior in major mood disorders. Ann N Y Acad Sci 1997;836:339-51.
8. Goodwin FK, Fireman B, Simon GE, et al. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 2003;290:1467-73.
9. Cipriani A, Pretty H, Hawton K, Geddes JR. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: A systematic review of randomized trials. Am J Psychiatry 2005;162:1805-19.
10. Hirschfeld RM, Vornik LA. Bipolar disorder - Costs and comorbidity. Am J Manag Care 2005;11(suppl 3):S85-90.
11. Marcus SC, Olfson M, Pincus HA, et al. Therapeutic drug monitoring of mood stabilizers in Medicaid patients with bipolar disorder. Am J Psychiatry 1999:156:1014-18.
12. JeffersonJW. Finger-sticklithiumtest: In-office alternative to laboratory-based methods. Current Psychiatry 2005;4(10):111-17.
13. InstaRead Lithium System. Med Lett Drugs Ther 2005;47(1219):82-3.
14. ReliaLab, Inc. 2N. Finley St., Basking Ridge, NJ 07920. (866) 467-8273. www.relialab.com.
15. Kohn LT, Corrigan JM, Donaldson MS, eds. Institute of Medicine. Committee on Quality of Health Care in America. To Err Is Human: Building a Safer Health System. Washington, D.C.: National Academy Press, 2000. Available at: www.nap.edu/books/0309068371/html.
16. Schoen C, Osborn R, Trang Huynh P, et al. Taking the pulse of health care systems : Experiences of patients with health problems in six countries. Health Affairs 2005:W5-509, W5-525.
17. Schmidt CW Jr, Yowell RK, Jaffe E. CPT Handbookfor Psychiatrists. 3rd ed. Washington, D.C.:APPI, Inc., 2004.